| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.006 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |